Quick Answer
CEMTREX INC reported R&D Expense of $2.35 million for fiscal year 2025.
CEMTREX INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $2.35M | -29.9% |
| 2024 | $3.36M | +2.7% |
| 2023 | $3.27M | -26.5% |
| 2022 | $4.44M | +40.1% |
| 2021 | $3.17M | +73.6% |
| 2020 | $1.83M | +23.3% |
| 2019 | $1.48M | -73.3% |
| 2018 | $5.56M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $501.4K | -43.7% | +29.7% |
| June 30, 2025 | $386.6K | -55.3% | -50.3% |
| March 31, 2025 | $777.9K | -18.2% | -12.6% |
| December 31, 2024 | $890.1K | +4.9% | +3.0% |
| June 30, 2024 | $864.5K | -17.7% | -9.1% |
| March 31, 2024 | $951.4K | -41.1% | +12.1% |
| December 31, 2023 | $848.8K | -44.8% | -19.2% |
| June 30, 2023 | $1.05M | -11.8% | -35.0% |
- CEMTREX INC showed a decrease of -29.9% in R&D Expense compared to the prior fiscal year.
- Over the 2018–2025 period, CEMTREX INC’s r&d expense has declined by 57.7% (from $5.56 million to $2.35 million).
- The most recent figure is from CEMTREX INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: